Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pediatric Cancer Immunotherapy

Sarah Davis

MD

🏢Children's Hospital of Philadelphia🌐USA

Associate Professor of Pediatric Oncology

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Sarah Davis has advanced bispecific T cell engager therapy in pediatric hematologic malignancies, contributing key clinical data on blinatumomab efficacy and safety in children with relapsed acute lymphoblastic leukemia. Her research on immune-based consolidation strategies has helped define optimal sequencing of immunotherapy with conventional chemotherapy in pediatric ALL. She leads cooperative group studies evaluating novel bispecific antibody platforms for children.

Share:

🧪Research Fields 研究领域

Pediatric lymphoma immunotherapy
Blinatumomab pediatric use
BiTE antibodies in children
Relapsed ALL treatment
Immune-based consolidation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Sarah Davis 的研究动态

Follow Sarah Davis's research updates

留下邮箱,当我们发布与 Sarah Davis(Children's Hospital of Philadelphia)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment